Abstract
For detecting telomerase activity, a PCR-based technique known as TRAP assay was introduced in 1994. Since then, by innovating complementary design many alterations were applied to improve the quality of detection and reducing the problems occurred during amplification and detection of the telomerase products. Especially, such complications could occur in samples having low quantities of telomerase enzyme and/or PCR inhibitors. A new strategy focusing on re-amplification of the products could help the investigators to determine the majority of telomerase-positive samples.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Asker C, Wiman KG, Selivanova G (1999) P53-induced apoptosis as a safeguard against cancer. Biochem Biophys Res Commun 265:1–6
Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175–1184
Bednarek AK, Sahin A, Brenner AJ, Johnston DA, Aldaz CM (1997) Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin Cancer Res 3:11–16
Carey LA, Kim NW, Goodman S, Marks J, Henderson G, Umbricht CB, Dome JS, Dooley W, Amshey SR, Sukumar S (1999) Telomerase activity and prognosis in primary breast cancers. J Clin Oncol 17:3075–3081
Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBOJ 11:1921–1929
Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315–2320
Dejmek A, Yahata N, Ohyashiki K (2000) Correlation between morphology and telomerase activity in cells from exfoliative lung cytologic specimens. Cancer 90:117–125
Dejmek A, Yahata N, Ohyashiki K (2001) In situ telomerase activity in pleural effusions: a promising marker for malignancy. Diagn Cytopathol 24:11–15
Elkak AE, Kirkpatrik K, Mears L, Wells C, Ghilchik M, Newbold R, Mokbel K (2002) Telomerase activity and Bcl-2 expression in breast cancer. Eur J Surg Oncol 28:14–18
Elmore LW, Forsythe HL, Ferreira-Gonzalez A, Garrett CT, Clark GM, Holt SE (2002) Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assay. Diagn Mol Pathol 11:177–185
Fajkus J, Koppova K, Kunicka Z (2003) Dual-color real-time telomeric repeat amplification protocol. Biotechniques 35:912–914
Fajkus J (2006) Detection of telomerase activity by the TRAP assay and its variants and alternatives. Clinica Chemica Acta 371:25–31
Harle-Bachor C, Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93:6476–6481
Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345:458–460
Hirose M, Abe-Hashimoto J, Ogura K, Tahara H, Ide T, Yoshimura T (1997) A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J Cancer Res Clin Oncol 123:337–344
Huffman KE, Levene SD, Tesmer VM, Shay JW, Wright WE (2000) Telomere shortening is proportional to the size of the G-rich telomeric 3’-overhang. J Biol Chem 275:19719–19722
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015
Kimura M, Koida T, Yanagita Y (2003) A study on telomerase activity and prognosis in breast cancer. Med Oncol 20:117–126
Krupp G, Klapper W, Parwaresch R (2000) Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation. Cell Mol Life Sci 57:464–486
Lovedy RL, Greenman J, Drew PJ, Monson JRT, Kerin MJ (1999) Genetic changes associated with telomerase activity in breast cancer. Int J Cancer 84:516–520
Mokbel K, Parris CN, Radbourne R, Ghichik M, Newbold RF (1999a) Telomerase activity and prognosis in breast cancer. Eur J Surg Oncol 25:269–272
Mokbel K, Parris CN, Ghilchik M, Williams G, Newbold RF (1999b) The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer. Am J Surg 178:69–72
Mokbel K (2000a) The role of telomerase in breast cancer. Eur J Surg Oncol 26:509–514
Mokbel K, Williams NJ (2000b) Telomerase and breast cancer: from diagnosis to therapy. Int J Surg Investig 2:85–88
Mueller C, Riese U, Kosmehl H, Dahse R, Claussen U, Ernst G (2002) Telomerase activity in micro dissected human breast cancer tissues: association with p53, p21 and outcome. Int J Oncol 20:385–390
Nawaz S, Hashizumi TL, Markham NE, Shroyer AL, Shroyer KR (1997) Telomerase expression in human breast cancer with and without lymph node metastases. Am J Clin Pathol 107:542–547
Ohyashiki K, Ohyashiki JH, Nishimaki J (1997) Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 57:2100–2103
Ohyashiki K, Yahata N, Ohyashiki JH (1998) A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia. Cancer 83:2554–2560
Qui XG, Liu YP, Pu QT, Gu QH, Han JJ (2002) Significance of telomerase expression in diagnosis and treatment of breast tumor. Ai Zheng 21:1241–1243
Savoysky E, Akamatsu K, Tsuchiya M, Yamazaki T (1996) Detection of telomerase activity by combination of TRAP method and scintillation proximity assay (SPA). Nucleic Acids Res 24:1175–1186
Shah NG, Choksi TJ, Patel DD, Vora HH, Ghosh N, Trivedi TI, Trivedi KA (2002) Telomerase activity in breast cancer in Western India (Gujarat). Int J Biol Markers 17:49–55
Sugino T, Yoshida K, Bolodeoku J, Tahara H, Buley I, Manek S, Wells C, Goodison S, Ide T, Suzuki T, Tahara E, Tarin D (1996) Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer 69:301–306
Tsao J, Zhao Y, Lukas J, Yang X, Shah A, Press M, Shibata D (1997) Telomerase activity in normal and neoplastic breast. Clin Cancer Res 3:627–631
Wege H, Chui MS, Le HT, Tran JM, Zern MA (2003) SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res 31:E3
Wright WE, Shay JW (1992) The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27:383–389
Xin H (2011) Telomeres and telomerase: Methods and protocols, Methods in molecular biology, vol 735. © Springer Science + Business Media, LLC 2011, Heidelberg. doi:10.1007/978–1-61779–092-8_10
Yahata N, Ohyashiki K, Ohyashiki JH (1998) Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst 90:684–690
Yang W, Xu L, Zhang T (1999) Telomerase activity in breast carcinoma. Zhonghua Zhong Liu Za Zhi 21:278–280
Yano Y, Yoshida K, Osaki A, Toge T, Tahara H, Ide T, Yasui W (2002) Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues. Anticancer Res 22:4101–4107
Yashima K, Milchgrub S, Gollahon LS, Maitra A, Saboorian MH, Shay JW, Gazdar AF (1998) Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res 4:229–234
Youssef N, Paradis V, Ferlicot S, Bedossa P (2001) In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. J Pathol 194:459–465
Zuo X, Xia F, Patterson A, Soh HT, Xiao Y, Plaxco KW (2011) Two-step, PCR-free telomerase detection by using exonuclease III-aided target recycling. ChemBioChem 12:2745–2747
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Saied Hosseini-Asl, S., Mehdipour, P. (2013). Detection of Telomerase Activity: A New Strategy for Detecting Low Activity of Telomerase. In: Mehdipour, P. (eds) Telomere Territory and Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4632-9_3
Download citation
DOI: https://doi.org/10.1007/978-94-007-4632-9_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4631-2
Online ISBN: 978-94-007-4632-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)